Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT03900299 Active, not recruiting - Breast Cancer Clinical Trials

Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Multi-focal Breast Cancers(MFBC) still have undiscoverable Clinical Significance reflecting on a debatable surgical decision for this Category of breast cancer. A prospective study was conducted using certain surgical technique as a surgical treatment for female patients with operable breast cancer managed at the Surgical Oncology Unit, Alexandria University from May. 2017 to May2018 and will be followed for 3 Years.Analysis will be done to settle a paradigm for surgical management of Multi-focal Breast Cancer

NCT ID: NCT03894410 Active, not recruiting - Breast Cancer Clinical Trials

Treatment After Progression of Lapatinib Among Metastatic Breast Cancer Patients

Start date: January 10, 2019
Phase:
Study type: Observational

A Multicenter, Retrospective Study of Treatment after Progression on Lapatinib among Metastatic Breast Cancer (MBC) Patients in Clinical Practice.

NCT ID: NCT03880799 Active, not recruiting - Breast Cancer Clinical Trials

Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer

MEDITATE-BC
Start date: November 8, 2018
Phase: N/A
Study type: Interventional

In this study the investigators propose to pilot test a brief, mindfulness shared decision making intervention that begins shortly after receiving a diagnosis of breast cancer. A mindfulness instructor will conduct an hour long session with consented participants before the scheduled surgical appointment. The investigators hypothesize that a mindfulness intervention delivered shortly after receiving a diagnosis of breast cancer may ultimately lead to increased decisional satisfaction and alignment to participant's values and preferences, and decreased anxiety. To measure this endpoint, participants will complete three surveys via REDCap- at baseline, before surgery, and 6 months postoperatively. Surveys will include questions on quality of life, anxiety, and participant satisfaction with the mindfulness program.

NCT ID: NCT03852953 Active, not recruiting - Breast Cancer Clinical Trials

Under- and Overdiagnosis in BreastScreen Norway

Start date: July 1, 2018
Phase:
Study type: Observational

This PhD project will describe tumour characteristics and survival associated with of under- and overdiagnosed breast cancers, the rate of overdiagnosis in BreastScreen Norway, and whether women and family doctors are aware of, and knowledgeable about, under- and overdiagnosis in breast cancer screening.

NCT ID: NCT03847623 Active, not recruiting - Breast Cancer Clinical Trials

Effect of Preoperative Curcumin in Breast Cancer Patients

EPC
Start date: June 18, 2017
Phase: N/A
Study type: Interventional

Effect of curcumin on modulation of immune and inflammatory parameters in pre-operative patients

NCT ID: NCT03810625 Active, not recruiting - Breast Cancer Clinical Trials

Food Effect Study of D-0502 Tablet in Healthy Volunteers

Start date: October 18, 2018
Phase: Phase 1
Study type: Interventional

This is an open label, randomized, balanced, single dose, two-treatment (fed vs. fasting), two-period, two-sequence crossover study of postmenopausal female healthy subjects.

NCT ID: NCT03735550 Active, not recruiting - Breast Cancer Clinical Trials

Effectiveness of Liquid Crystal Contact Thermography in Detecting Pathological Changes in Female Breasts

Start date: February 1, 2017
Phase:
Study type: Observational

The study is designed to evaluate the effectiveness of liquid crystal contact thermography in detecting pathological changes in female breasts compared to standard diagnostic methods.

NCT ID: NCT03695341 Active, not recruiting - Breast Cancer Clinical Trials

500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

Start date: May 14, 2018
Phase:
Study type: Observational

500mg Fulvestrant versus Everolimus plus Exemestane in MBC patients refractory to previous AI

NCT ID: NCT03682744 Active, not recruiting - Breast Cancer Clinical Trials

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Start date: September 13, 2018
Phase: Phase 1
Study type: Interventional

This is an open-label, dose-escalation, phase I trial of the safety and efficacy of anti-CEA intraperitoneal CAR-T infusions for treatment in patients with CEA-expressing adenocarcinoma peritoneal metastases or malignant ascites.

NCT ID: NCT03673306 Active, not recruiting - Breast Cancer Clinical Trials

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

Start date: January 16, 2017
Phase:
Study type: Observational

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.